PEN
Penumbra IncPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 25 Penumbra reported strong 2025 full-year financial results with reven…
- Apr 1 ▲ Penumbra Inc is being acquired by Boston Scientific in a mixed cash-…
- Apr 2 ▼ 1 insider sell $32.8K at $328.22
- May 6 ▼ Penumbra Q1 2026 earnings miss: diluted EPS of $0.82 missed consensu…
- May 7 ▲ Penumbra shareholders voted overwhelmingly to approve the merger wit…
- Jul 30 ▼ Penumbra reported Q2 2026 revenue of $390.0M (+14.9% YoY), in line w…
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider sold $32.8K.
- InstitutionsBEARISH
Q2 2026: 31 added (1 new), 48 trimmed or exited. Largest new: Westfield Capital Management $41.5M.
- Short sellersSTEADY
Short interest +6.2% to 2.40M shares. 5.3 days to cover, ≈6.1% of shares.
- TrendUPTREND
0% above its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| ExodusPoint Capital Management, LP | DOUBLED | $344.3M |
| BALYASNY ASSET MANAGEMENT L.P. | ADD | $344.2M |
| JPMORGAN CHASE & CO | DOUBLED | $338.6M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | $263.6M |
| NORGES BANK | DOUBLED | $237.5M |
| UBS Group AG | ADD | $222.2M |
| MILLENNIUM MANAGEMENT LLC | TRIM | $221.2M |
| MORGAN STANLEY | ADD | $186.9M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Jul 2026Price is inside the target range. Median implies +17%.Targets as of Nov 16, 2026.
| Date | Firm | Rating |
|---|---|---|
| Jul 6, 2026 | Evercore ISI Group MAINTAIN | Outperform |
| Jun 11, 2026 | RBC Capital REITERATE | Sector Perform |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Narayan Shruthi President Oct 15, 2026 | TAX W/H | $439.1K |
Narayan Shruthi President Sep 15, 2026 | TAX W/H | $391.7K |
Narayan Shruthi President Aug 17, 2026 | AWARD | 3,060 sh |
Elsesser Adam CEO May 19, 2026 | GIFT | 77,000 sh |
Grewal Harpreet Director Apr 2, 2026 | SELL | $32.8K |
Narayan Shruthi President Mar 15, 2026 | TAX W/H | $39.3K |
Shiu Lambert Chief Accounting Officer Mar 15, 2026 | TAX W/H | $50.4K |
Yuen Maggie Chief Financial Officer Mar 15, 2026 | TAX W/H | $62.5K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
11 filings · 2 bullish · 2 bearish · 2 mixed · 5 neutral- MIXED INST-CLUSTERNov 9, 2026
Institutional activity in Penumbra during Q3 2026 was mixed: 8 buyers added $18.0M in new…
The cluster shows a clear divergence: large European asset managers are reducing exposure while Barclays and smaller managers are adding. Monitor next 13F for continuation of this trend and any…
- NEUTRAL SC 13G/ANov 6, 2026
Barclays PLC filed an amended Schedule 13G disclosing a 4.82% passive stake in Penumbra Inc as of…
Barclays' slight reduction is routine portfolio rebalancing by a passive holder. No change in investment intent. Monitor for any future conversion to 13D or further trimming below 5%.
- NEUTRAL 8-KOct 29, 2026
Revenue beat consensus, but EPS missed. The company continues to not provide guidance due to the…
The EPS miss and declining net income YoY are notable, but the revenue beat and strong thrombectomy growth (especially U.S. VTE at +26%) show solid operational performance. The pending Boston…
- NEUTRAL PRESS-RELEASEOct 29, 2026
Penumbra reported Q3 2026 revenue of $410.1M, up 15.6% YoY and above the $400.1M consensus, with…
The pending Boston Scientific acquisition overrides near-term earnings dynamics. Monitor regulatory approval milestones and any updates on the merger timeline, as deal completion is the primary…
All PEN filing & press-release reports (11)
- INST-CLUSTER reportNov 9, 2026
- SC 13G/A reportNov 6, 2026
- 8-K reportOct 29, 2026
- PRESS-RELEASE reportOct 29, 2026
- PRESS-RELEASE reportJul 30, 2026
- 425 reportMay 7, 2026
- 8-K reportMay 6, 2026
- DEFA14A reportApr 29, 2026
- 425 reportApr 17, 2026
- DEFM14A reportApr 1, 2026
- 8-K reportFeb 25, 2026